NCT00004644View on ClinicalTrials.gov

Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 1995

Conditions
Herpes Simplex
Interventions
DRUG

acyclovir

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

National Center for Research Resources (NCRR)

NIH